EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 84 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,259,109 | -2.8% | 533,055 | +5.8% | 0.00% | – |
Q2 2023 | $4,382,016 | +231.1% | 503,680 | +11.9% | 0.00% | – |
Q1 2023 | $1,323,662 | -58.0% | 450,225 | -49.9% | 0.00% | – |
Q4 2022 | $3,148,292 | -8.2% | 899,512 | +107.4% | 0.00% | – |
Q3 2022 | $3,431,000 | +7.9% | 433,732 | +7.3% | 0.00% | – |
Q2 2022 | $3,180,000 | -30.3% | 404,060 | +7.6% | 0.00% | – |
Q1 2022 | $4,562,000 | +4.3% | 375,470 | +5.1% | 0.00% | – |
Q4 2021 | $4,374,000 | +38.7% | 357,361 | +18.1% | 0.00% | – |
Q3 2021 | $3,153,000 | +54.7% | 302,629 | +33.5% | 0.00% | – |
Q2 2021 | $2,038,000 | – | 226,649 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,190,921 | $36,461,013 | 27.59% |
ACUTA CAPITAL PARTNERS, LLC | 382,000 | $3,323,400 | 2.25% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,423,897 | $29,787,904 | 1.59% |
Cormorant Asset Management, LP | 3,200,000 | $27,840,000 | 1.56% |
Caligan Partners LP | 310,298 | $2,699,593 | 1.52% |
Samsara BioCapital, LLC | 432,000 | $3,758,400 | 0.66% |
RA Capital Management | 3,370,506 | $29,323,402 | 0.55% |
SECTORAL ASSET MANAGEMENT INC | 311,277 | $2,708,110 | 0.45% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 209,949 | $1,826,556 | 0.26% |
BARD ASSOCIATES INC | 30,674 | $266,864 | 0.10% |